Maximize Exosome Yields Using a Chemically Defined Bioreactor Media System

Scaling exosome manufacturing requires more than increasing bioreactor volume. Upstream productivity, downstream recovery, media composition, analytics, and process consistency can all influence whether a workflow remains practical as programs advance toward clinical manufacturing.

Explore strategies for increasing MSC-derived exosome yields using chemically defined media and bioreactor-based processes. See how process intensification can extend culture duration, eliminate media exchanges, and increase exosome production while maintaining key quality attributes such as identity and potency. The discussion also examines downstream filtration challenges, including how conditioned media viscosity can affect recovery, and approaches for improving exosome yield during processing.

With examples comparing legacy workflows to intensified manufacturing strategies, gain practical insight into building a scalable, GMP-ready process while considering cost per dose, critical quality attributes, and future clinical requirements.

Watch the full webinar to explore approaches for improving exosome manufacturing from upstream production through downstream recovery.